Global Oncology/Anti-Cancer Drugs Market Professional Survey Report 2017

November 2017 | 101 pages | ID: GC07B00D3C4WEN
QYResearch

Abstracts

This report studies Oncology/Anti-Cancer Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Amgen
• AstraZeneca
• Roche Diagnostics
• GlaxoSmithKline
• Merck
• Novartis
• AbbVie
• Sanofi
• EIMC United Pharmaceuticals
• Actavis

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Chemotherapy
• Targeted Therapy
• Immunotherapy (Biologic Therapy)
• Hormonal Therapy
• Others

By Application, the market can be split into

• Blood Cancer (Leukaemia)
• Breast Cancer
• Gastrointestinal Cancer
• Respiratory/Lung Cancer
• Skin Cancer
• Other Cancers

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Oncology/Anti-Cancer Drugs Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF ONCOLOGY/ANTI-CANCER DRUGS

1.1 Definition and Specifications of Oncology/Anti-Cancer Drugs
  1.1.1 Definition of Oncology/Anti-Cancer Drugs
  1.1.2 Specifications of Oncology/Anti-Cancer Drugs
1.2 Classification of Oncology/Anti-Cancer Drugs
  1.2.1 Chemotherapy
  1.2.2 Targeted Therapy
  1.2.3 Immunotherapy (Biologic Therapy)
  1.2.4 Hormonal Therapy
  1.2.5 Others
1.3 Applications of Oncology/Anti-Cancer Drugs
  1.3.1 Blood Cancer (Leukaemia)
  1.3.2 Breast Cancer
  1.3.3 Gastrointestinal Cancer
  1.3.4 Respiratory/Lung Cancer
  1.3.5 Skin Cancer
  1.3.6 Other Cancers
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF ONCOLOGY/ANTI-CANCER DRUGS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Oncology/Anti-Cancer Drugs
2.3 Manufacturing Process Analysis of Oncology/Anti-Cancer Drugs
2.4 Industry Chain Structure of Oncology/Anti-Cancer Drugs

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF ONCOLOGY/ANTI-CANCER DRUGS

3.1 Capacity and Commercial Production Date of Global Oncology/Anti-Cancer Drugs Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Oncology/Anti-Cancer Drugs Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Oncology/Anti-Cancer Drugs Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Oncology/Anti-Cancer Drugs Major Manufacturers in 2016

4 GLOBAL ONCOLOGY/ANTI-CANCER DRUGS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Oncology/Anti-Cancer Drugs Capacity and Growth Rate Analysis
  4.2.2 2016 Oncology/Anti-Cancer Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Oncology/Anti-Cancer Drugs Sales and Growth Rate Analysis
  4.3.2 2016 Oncology/Anti-Cancer Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Oncology/Anti-Cancer Drugs Sales Price
  4.4.2 2016 Oncology/Anti-Cancer Drugs Sales Price Analysis (Company Segment)

5 ONCOLOGY/ANTI-CANCER DRUGS REGIONAL MARKET ANALYSIS

5.1 North America Oncology/Anti-Cancer Drugs Market Analysis
  5.1.1 North America Oncology/Anti-Cancer Drugs Market Overview
  5.1.2 North America 2012-2017E Oncology/Anti-Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Oncology/Anti-Cancer Drugs Sales Price Analysis
  5.1.4 North America 2016 Oncology/Anti-Cancer Drugs Market Share Analysis
5.2 China Oncology/Anti-Cancer Drugs Market Analysis
  5.2.1 China Oncology/Anti-Cancer Drugs Market Overview
  5.2.2 China 2012-2017E Oncology/Anti-Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Oncology/Anti-Cancer Drugs Sales Price Analysis
  5.2.4 China 2016 Oncology/Anti-Cancer Drugs Market Share Analysis
5.3 Europe Oncology/Anti-Cancer Drugs Market Analysis
  5.3.1 Europe Oncology/Anti-Cancer Drugs Market Overview
  5.3.2 Europe 2012-2017E Oncology/Anti-Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Oncology/Anti-Cancer Drugs Sales Price Analysis
  5.3.4 Europe 2016 Oncology/Anti-Cancer Drugs Market Share Analysis
5.4 Southeast Asia Oncology/Anti-Cancer Drugs Market Analysis
  5.4.1 Southeast Asia Oncology/Anti-Cancer Drugs Market Overview
  5.4.2 Southeast Asia 2012-2017E Oncology/Anti-Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Oncology/Anti-Cancer Drugs Sales Price Analysis
  5.4.4 Southeast Asia 2016 Oncology/Anti-Cancer Drugs Market Share Analysis
5.5 Japan Oncology/Anti-Cancer Drugs Market Analysis
  5.5.1 Japan Oncology/Anti-Cancer Drugs Market Overview
  5.5.2 Japan 2012-2017E Oncology/Anti-Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Oncology/Anti-Cancer Drugs Sales Price Analysis
  5.5.4 Japan 2016 Oncology/Anti-Cancer Drugs Market Share Analysis
5.6 India Oncology/Anti-Cancer Drugs Market Analysis
  5.6.1 India Oncology/Anti-Cancer Drugs Market Overview
  5.6.2 India 2012-2017E Oncology/Anti-Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Oncology/Anti-Cancer Drugs Sales Price Analysis
  5.6.4 India 2016 Oncology/Anti-Cancer Drugs Market Share Analysis

6 GLOBAL 2012-2017E ONCOLOGY/ANTI-CANCER DRUGS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Oncology/Anti-Cancer Drugs Sales by Type
6.2 Different Types of Oncology/Anti-Cancer Drugs Product Interview Price Analysis
6.3 Different Types of Oncology/Anti-Cancer Drugs Product Driving Factors Analysis
  6.3.1 Chemotherapy of Oncology/Anti-Cancer Drugs Growth Driving Factor Analysis
  6.3.2 Targeted Therapy of Oncology/Anti-Cancer Drugs Growth Driving Factor Analysis
  6.3.3 Immunotherapy (Biologic Therapy) of Oncology/Anti-Cancer Drugs Growth Driving Factor Analysis
  6.3.4 Hormonal Therapy of Oncology/Anti-Cancer Drugs Growth Driving Factor Analysis
  6.3.5 Others of Oncology/Anti-Cancer Drugs Growth Driving Factor Analysis

7 GLOBAL 2012-2017E ONCOLOGY/ANTI-CANCER DRUGS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Oncology/Anti-Cancer Drugs Consumption by Application
7.2 Different Application of Oncology/Anti-Cancer Drugs Product Interview Price Analysis
7.3 Different Application of Oncology/Anti-Cancer Drugs Product Driving Factors Analysis
  7.3.1 Blood Cancer (Leukaemia) of Oncology/Anti-Cancer Drugs Growth Driving Factor Analysis
  7.3.2 Breast Cancer of Oncology/Anti-Cancer Drugs Growth Driving Factor Analysis
  7.3.3 Gastrointestinal Cancer of Oncology/Anti-Cancer Drugs Growth Driving Factor Analysis
  7.3.4 Respiratory/Lung Cancer of Oncology/Anti-Cancer Drugs Growth Driving Factor Analysis
  7.3.5 Skin Cancer of Oncology/Anti-Cancer Drugs Growth Driving Factor Analysis
  7.3.6 Other Cancers of Oncology/Anti-Cancer Drugs Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF ONCOLOGY/ANTI-CANCER DRUGS

8.1 Amgen
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Amgen 2016 Oncology/Anti-Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Amgen 2016 Oncology/Anti-Cancer Drugs Business Region Distribution Analysis
8.2 AstraZeneca
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 AstraZeneca 2016 Oncology/Anti-Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 AstraZeneca 2016 Oncology/Anti-Cancer Drugs Business Region Distribution Analysis
8.3 Roche Diagnostics
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Roche Diagnostics 2016 Oncology/Anti-Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Roche Diagnostics 2016 Oncology/Anti-Cancer Drugs Business Region Distribution Analysis
8.4 GlaxoSmithKline
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 GlaxoSmithKline 2016 Oncology/Anti-Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 GlaxoSmithKline 2016 Oncology/Anti-Cancer Drugs Business Region Distribution Analysis
8.5 Merck
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Merck 2016 Oncology/Anti-Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Merck 2016 Oncology/Anti-Cancer Drugs Business Region Distribution Analysis
8.6 Novartis
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Novartis 2016 Oncology/Anti-Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Novartis 2016 Oncology/Anti-Cancer Drugs Business Region Distribution Analysis
8.7 AbbVie
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 AbbVie 2016 Oncology/Anti-Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 AbbVie 2016 Oncology/Anti-Cancer Drugs Business Region Distribution Analysis
8.8 Sanofi
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Sanofi 2016 Oncology/Anti-Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Sanofi 2016 Oncology/Anti-Cancer Drugs Business Region Distribution Analysis
8.9 EIMC United Pharmaceuticals
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 EIMC United Pharmaceuticals 2016 Oncology/Anti-Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 EIMC United Pharmaceuticals 2016 Oncology/Anti-Cancer Drugs Business Region Distribution Analysis
8.10 Actavis
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Actavis 2016 Oncology/Anti-Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Actavis 2016 Oncology/Anti-Cancer Drugs Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF ONCOLOGY/ANTI-CANCER DRUGS MARKET

9.1 Global Oncology/Anti-Cancer Drugs Market Trend Analysis
  9.1.1 Global 2017-2022 Oncology/Anti-Cancer Drugs Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Oncology/Anti-Cancer Drugs Sales Price Forecast
9.2 Oncology/Anti-Cancer Drugs Regional Market Trend
  9.2.1 North America 2017-2022 Oncology/Anti-Cancer Drugs Consumption Forecast
  9.2.2 China 2017-2022 Oncology/Anti-Cancer Drugs Consumption Forecast
  9.2.3 Europe 2017-2022 Oncology/Anti-Cancer Drugs Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Oncology/Anti-Cancer Drugs Consumption Forecast
  9.2.5 Japan 2017-2022 Oncology/Anti-Cancer Drugs Consumption Forecast
  9.2.6 India 2017-2022 Oncology/Anti-Cancer Drugs Consumption Forecast
9.3 Oncology/Anti-Cancer Drugs Market Trend (Product Type)
9.4 Oncology/Anti-Cancer Drugs Market Trend (Application)

10 ONCOLOGY/ANTI-CANCER DRUGS MARKETING TYPE ANALYSIS

10.1 Oncology/Anti-Cancer Drugs Regional Marketing Type Analysis
10.2 Oncology/Anti-Cancer Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Oncology/Anti-Cancer Drugs by Region
10.4 Oncology/Anti-Cancer Drugs Supply Chain Analysis

11 CONSUMERS ANALYSIS OF ONCOLOGY/ANTI-CANCER DRUGS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL ONCOLOGY/ANTI-CANCER DRUGS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Oncology/Anti-Cancer Drugs
Table Product Specifications of Oncology/Anti-Cancer Drugs
Table Classification of Oncology/Anti-Cancer Drugs
Figure Global Production Market Share of Oncology/Anti-Cancer Drugs by Type in 2016
Figure Chemotherapy Picture
Table Major Manufacturers of Chemotherapy
Figure Targeted Therapy Picture
Table Major Manufacturers of Targeted Therapy
Figure Immunotherapy (Biologic Therapy) Picture
Table Major Manufacturers of Immunotherapy (Biologic Therapy)
Figure Hormonal Therapy Picture
Table Major Manufacturers of Hormonal Therapy
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Oncology/Anti-Cancer Drugs
Figure Global Consumption Volume Market Share of Oncology/Anti-Cancer Drugs by Application in 2016
Figure Blood Cancer (Leukaemia) Examples
Table Major Consumers in Blood Cancer (Leukaemia)
Figure Breast Cancer Examples
Table Major Consumers in Breast Cancer
Figure Gastrointestinal Cancer Examples
Table Major Consumers in Gastrointestinal Cancer
Figure Respiratory/Lung Cancer Examples
Table Major Consumers in Respiratory/Lung Cancer
Figure Skin Cancer Examples
Table Major Consumers in Skin Cancer
Figure Other Cancers Examples
Table Major Consumers in Other Cancers
Figure Market Share of Oncology/Anti-Cancer Drugs by Regions
Figure North America Oncology/Anti-Cancer Drugs Market Size (Million USD) (2012-2022)
Figure China Oncology/Anti-Cancer Drugs Market Size (Million USD) (2012-2022)
Figure Europe Oncology/Anti-Cancer Drugs Market Size (Million USD) (2012-2022)
Figure Southeast Asia Oncology/Anti-Cancer Drugs Market Size (Million USD) (2012-2022)
Figure Japan Oncology/Anti-Cancer Drugs Market Size (Million USD) (2012-2022)
Figure India Oncology/Anti-Cancer Drugs Market Size (Million USD) (2012-2022)
Table Oncology/Anti-Cancer Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Oncology/Anti-Cancer Drugs in 2016
Figure Manufacturing Process Analysis of Oncology/Anti-Cancer Drugs
Figure Industry Chain Structure of Oncology/Anti-Cancer Drugs
Table Capacity and Commercial Production Date of Global Oncology/Anti-Cancer Drugs Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Oncology/Anti-Cancer Drugs Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Oncology/Anti-Cancer Drugs Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Oncology/Anti-Cancer Drugs Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Oncology/Anti-Cancer Drugs 2012-2017
Figure Global 2012-2017E Oncology/Anti-Cancer Drugs Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Oncology/Anti-Cancer Drugs Market Size (Value) and Growth Rate
Table 2012-2017E Global Oncology/Anti-Cancer Drugs Capacity and Growth Rate
Table 2016 Global Oncology/Anti-Cancer Drugs Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate
Table 2016 Global Oncology/Anti-Cancer Drugs Sales (K Units) List (Company Segment)
Table 2012-2017E Global Oncology/Anti-Cancer Drugs Sales Price (USD/Unit)
Table 2016 Global Oncology/Anti-Cancer Drugs Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Oncology/Anti-Cancer Drugs 2012-2017E
Figure North America 2012-2017E Oncology/Anti-Cancer Drugs Sales Price (USD/Unit)
Figure North America 2016 Oncology/Anti-Cancer Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Oncology/Anti-Cancer Drugs 2012-2017E
Figure China 2012-2017E Oncology/Anti-Cancer Drugs Sales Price (USD/Unit)
Figure China 2016 Oncology/Anti-Cancer Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Oncology/Anti-Cancer Drugs 2012-2017E
Figure Europe 2012-2017E Oncology/Anti-Cancer Drugs Sales Price (USD/Unit)
Figure Europe 2016 Oncology/Anti-Cancer Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Oncology/Anti-Cancer Drugs 2012-2017E
Figure Southeast Asia 2012-2017E Oncology/Anti-Cancer Drugs Sales Price (USD/Unit)
Figure Southeast Asia 2016 Oncology/Anti-Cancer Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Oncology/Anti-Cancer Drugs 2012-2017E
Figure Japan 2012-2017E Oncology/Anti-Cancer Drugs Sales Price (USD/Unit)
Figure Japan 2016 Oncology/Anti-Cancer Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Oncology/Anti-Cancer Drugs 2012-2017E
Figure India 2012-2017E Oncology/Anti-Cancer Drugs Sales Price (USD/Unit)
Figure India 2016 Oncology/Anti-Cancer Drugs Sales Market Share
Table Global 2012-2017E Oncology/Anti-Cancer Drugs Sales (K Units) by Type
Table Different Types Oncology/Anti-Cancer Drugs Product Interview Price
Table Global 2012-2017E Oncology/Anti-Cancer Drugs Sales (K Units) by Application
Table Different Application Oncology/Anti-Cancer Drugs Product Interview Price
Table Amgen Information List
Table Product A Overview
Table Product B Overview
Table 2016 Amgen Oncology/Anti-Cancer Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Amgen Oncology/Anti-Cancer Drugs Business Region Distribution
Table AstraZeneca Information List
Table Product A Overview
Table Product B Overview
Table 2016 AstraZeneca Oncology/Anti-Cancer Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 AstraZeneca Oncology/Anti-Cancer Drugs Business Region Distribution
Table Roche Diagnostics Information List
Table Product A Overview
Table Product B Overview
Table 2015 Roche Diagnostics Oncology/Anti-Cancer Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Roche Diagnostics Oncology/Anti-Cancer Drugs Business Region Distribution
Table GlaxoSmithKline Information List
Table Product A Overview
Table Product B Overview
Table 2016 GlaxoSmithKline Oncology/Anti-Cancer Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 GlaxoSmithKline Oncology/Anti-Cancer Drugs Business Region Distribution
Table Merck Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck Oncology/Anti-Cancer Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Merck Oncology/Anti-Cancer Drugs Business Region Distribution
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis Oncology/Anti-Cancer Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Novartis Oncology/Anti-Cancer Drugs Business Region Distribution
Table AbbVie Information List
Table Product A Overview
Table Product B Overview
Table 2016 AbbVie Oncology/Anti-Cancer Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 AbbVie Oncology/Anti-Cancer Drugs Business Region Distribution
Table Sanofi Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sanofi Oncology/Anti-Cancer Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Sanofi Oncology/Anti-Cancer Drugs Business Region Distribution
Table EIMC United Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Business Region Distribution
Table Actavis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Actavis Oncology/Anti-Cancer Drugs Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Actavis Oncology/Anti-Cancer Drugs Business Region Distribution
Figure Global 2017-2022 Oncology/Anti-Cancer Drugs Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Oncology/Anti-Cancer Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Oncology/Anti-Cancer Drugs Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Oncology/Anti-Cancer Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Oncology/Anti-Cancer Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Oncology/Anti-Cancer Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Oncology/Anti-Cancer Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Oncology/Anti-Cancer Drugs Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Oncology/Anti-Cancer Drugs Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Oncology/Anti-Cancer Drugs by Type 2017-2022
Table Global Consumption Volume (K Units) of Oncology/Anti-Cancer Drugs by Application 2017-2022
Table Traders or Distributors with Contact Information of Oncology/Anti-Cancer Drugs by Region